HLA-DQ alleles in patients with cutaneous leishmaniasis in Sri Lanka: a preliminary report

Samaranayake, T.N.; Balaji, K.; Fernando, S.D.; Jayasekara, R.W.; Dissanayake, V.H.W.

dc.contributor.author	Samaranayake, T.N.
dc.contributor.author	Balaji, K.
dc.contributor.author	Fernando, S.D.
dc.contributor.author	Jayasekara, R.W.
dc.contributor.author	Dissanayake, V.H.W.
dc.date.accessioned	2012-12-20T08:06:30Z
dc.date.available	2012-12-20T08:06:30Z
dc.date.issued	2012
dc.identifier.citation	Annual Research Symposium	en_US
dc.identifier.uri	http://archive.cmb.ac.lk:8080/xmlui/handle/70130/3400
dc.description.abstract	Leishmanisis is an endemic disease in Sri Lanka with localized cutaneous leishmaniasis (LCL) continuing to be the predominant form to be reported. L. donovani, the parasite isolated from cutaneous lesions in Sri Lanka, is commonly known to cause the visceral form of the disease, in foci around the world. Polymorphisms of human leucocytes antigen (HLA) system have been implicated in susceptibility as well as the phenotype of leishmaniasis.
dc.language.iso	en	en_US
dc.title	HLA-DQ alleles in patients with cutaneous leishmaniasis in Sri Lanka: a preliminary report	en_US
dc.type	Research abstract	en_US